| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.0096 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |